Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Overview of the Therapeutic Strategies for the Treatment of Spinal Muscular Atrophy. | Hum Gene Ther | 2023 | 36762938 | PubTator, text mining | PubMed |
| Surgical correction of a ventricular septal defect in a child with spinal muscular atrophy type 2 treated with nusinersen sodium: a case report. | J Cardiothorac Surg | 2023 | 36759863 | PubTator, text mining | PubMed |
| Limb girdle muscular disease caused by HMGCR mutation and statin myopathy treatable with mevalonolactone. | Proc Natl Acad Sci U S A | 2023 | 36745799 | PubTator, text mining | PubMed |
| SYF2 suppression mitigates neurodegeneration in models of diverse forms of ALS. | Cell Stem Cell | 2023 | 36736291 | PubTator, text mining | PubMed |
| Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs. | Nucleic Acid Ther | 2023 | 36735616 | PubTator, text mining | PubMed |
| Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA). | J Neurol | 2023 | 36735057 | PubTator, text mining | PubMed |
| Targeting RNA with small molecules: lessons learned from Xist RNA. | RNA | 2023 | 36725318 | PubTator, text mining | PubMed |
| Therapeutics in paediatric genetic diseases: Current and future landscape. | Singapore Med J | 2023 | 36722512 | PubTator, text mining | PubMed |
| DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via a subcutaneous administration. | JCI Insight | 2023 | 36719755 | PubTator, text mining | PubMed |
| Technical feasibility of newborn screening for spinal muscular atrophy by next-generation DNA sequencing. | Front Genet | 2023 | 36713073 | PubTator, text mining | PubMed |
| Biocatalytic Synthesis of Antiviral Nucleosides, Cyclic Dinucleotides, and Oligonucleotide Therapies. | JACS Au | 2023 | 36711092 | PubTator, text mining | PubMed |
| The genomic landscape of rare disorders in the Middle East. | Genome Med | 2023 | 36703223 | PubTator, text mining | PubMed |
| Future directions for medicinal chemistry in the field of oligonucleotide therapeutics. | RNA | 2023 | 36693762 | PubTator, text mining | PubMed |
| Assessment of motor function and nutritional status in children with spinal muscular atrophy treated with nusinersen after loading period in Western China: a retrospective study. | BMC Neurol | 2023 | 36690929 | PubTator, text mining | PubMed |
| How does precursor RNA structure influence RNA processing and gene expression? | Biosci Rep | 2023 | 36689327 | PubTator, text mining | PubMed |
| RNA therapeutics in the clinic. | Bioeng Transl Med | 2023 | 36684099 | PubTator, text mining | PubMed |
| What Can RNA-Based Therapy Do for Monogenic Diseases? | Pharmaceutics | 2023 | 36678889 | PubTator, text mining | PubMed |
| Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study. | Pharmaceutics | 2023 | 36678797 | PubTator, text mining | PubMed |
| Comparative Evaluation of Reproducibility of Phage-Displayed Peptide Selections and NGS Data, through High-Fidelity Mapping of Massive Peptide Repertoires. | Int J Mol Sci | 2023 | 36675109 | PubTator, text mining | PubMed |
| Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives. | Int J Mol Sci | 2023 | 36674643 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=35